Myers MB - Search Results

1

A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroid.

Myers MB, McKim KL, Parsons BL. Myers MB, et al. Mol Carcinog. 2014 Feb;53(2):159-67. doi: 10.1002/mc.21953. Epub 2012 Aug 28. Mol Carcinog. 2014. PMID: 22930660

2

Oncomutations as biomarkers of cancer risk.

Parsons BL, Myers MB, Meng F, Wang Y, McKinzie PB. Parsons BL, et al. Among authors: myers mb. Environ Mol Mutagen. 2010 Oct-Dec;51(8-9):836-50. doi: 10.1002/em.20600. Environ Mol Mutagen. 2010. PMID: 20740637 Review.

3

p53 codon 271 CGT to CAT mutant fraction does not increase in nasal respiratory and olfactory epithelia of rats exposed to inhaled naphthalene.

Meng F, Wang Y, Myers MB, Wong BA, Gross EA, Clewell HJ 3rd, Dodd DE, Parsons BL. Meng F, et al. Among authors: myers mb. Mutat Res. 2011 Apr 3;721(2):199-205. doi: 10.1016/j.mrgentox.2011.02.004. Epub 2011 Feb 13. Mutat Res. 2011. PMID: 21324376

4

ACB-PCR measurement of H-ras codon 61 CAA→CTA mutation provides an early indication of aristolochic acid I carcinogenic effect in tumor target tissues.

Wang Y, Arlt VM, Roufosse CA, McKim KL, Myers MB, Phillips DH, Parsons BL. Wang Y, et al. Among authors: myers mb. Environ Mol Mutagen. 2012 Aug;53(7):495-504. doi: 10.1002/em.21710. Epub 2012 Jun 25. Environ Mol Mutagen. 2012. PMID: 22729866

5

Hotspot oncomutations: implications for personalized cancer treatment.

Myers MB, Wang Y, McKim KL, Parsons BL. Myers MB, et al. Expert Rev Mol Diagn. 2012 Jul;12(6):603-20. doi: 10.1586/erm.12.51. Expert Rev Mol Diagn. 2012. PMID: 22845481 Review.

6

Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water.

O'Brien TJ, Ding H, Suh M, Thompson CM, Parsons BL, Harris MA, Winkelman WA, Wolf JC, Hixon JG, Schwartz AM, Myers MB, Haws LC, Proctor DM. O'Brien TJ, et al. Among authors: myers mb. Mutat Res. 2013 Jun 14;754(1-2):15-21. doi: 10.1016/j.mrgentox.2013.03.008. Epub 2013 Apr 9. Mutat Res. 2013. PMID: 23583686 Free article.

7

Personalized cancer treatment and the myth of KRAS wild-type colon tumors.

Parsons BL, Myers MB. Parsons BL, et al. Among authors: myers mb. Discov Med. 2013 Apr;15(83):259-67. Discov Med. 2013. PMID: 23636143 Free article. Review.

8

Temporal changes in K-ras mutant fraction in lung tissue of big blue B6C3F₁ mice exposed to ethylene oxide.

Parsons BL, Manjanatha MG, Myers MB, McKim KL, Shelton SD, Wang Y, Gollapudi BB, Moore NP, Haber LT, Moore MM. Parsons BL, et al. Among authors: myers mb. Toxicol Sci. 2013 Nov;136(1):26-38. doi: 10.1093/toxsci/kft190. Epub 2013 Sep 12. Toxicol Sci. 2013. PMID: 24029818

9

ACB-PCR quantification of somatic oncomutation.

Myers MB, McKinzie PB, Wang Y, Meng F, Parsons BL. Myers MB, et al. Methods Mol Biol. 2014;1105:345-63. doi: 10.1007/978-1-62703-739-6_27. Methods Mol Biol. 2014. PMID: 24623241

10

Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas.

Myers MB, Banda M, McKim KL, Wang Y, Powell MJ, Parsons BL. Myers MB, et al. Neoplasia. 2016 Apr;18(4):253-63. doi: 10.1016/j.neo.2016.03.002. Neoplasia. 2016. PMID: 27108388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters